Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02118922 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 years 11 months later Sep 2026 → Sep 2030
See other at-risk trials from Massachusetts General Hospital

Record History

  1. Notable Primary and study completion pushed from Sep 2026 to Sep 2030 Site contact updated · Publications: details revised at 4 of 4 entries · Eligibility criteria expanded, about 3 words Show 3 more changesShow less
    • Site contact updated
    • Publications: details revised at 4 of 4 entries
    • Eligibility criteria expanded, about 3 words
  2. Minor Re-verified, no change to tracked fieldsv6
  3. Notable Primary and study completion dates: Sep 2025 to Sep 2026v5
  4. Minor Re-verified, no change to tracked fieldsv4
  5. Notable Primary and study completion dates: Sep 2020 to Sep 2025v3
  6. Notable Enrollment target: 28 to 168 Primary completion date: Feb 2016 to Sep 2020 · Completion date: Sep 2020 · Eligibility criteria expanded, about 171 words · 1 morev2 Show 4 more changesShow less
    • Primary completion date: Feb 2016 to Sep 2020
    • Completion date: Sep 2020
    • Eligibility criteria expanded, about 171 words
    • Study arms: 4 to 7

    See this version in full on ClinicalTrials.gov ↗

  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
We have developed novel Brillouin microscopy and we are testing its potential for keratoconus and ectasia diagnostics. We plan to perform axial scans of the cornea in human volunteers in order to compare biomechanical properties of Keratoconus vs. Normal corneas and compare biomechanical properties of post-LASIK ectasia vs. normal corneas.
Trial Details
NCT Number NCT02118922
Lead Sponsor Massachusetts General Hospital
Collaborators: Harvard Medical School (HMS and HSDM)
Conditions Keratoconus, Ectasia, Crosslinking, Fuchs' Endothelial Dystrophy
Enrollment 168 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov